Literature DB >> 3235959

Nine rheumatoid factor assays compared.

J P Jaspers1, R J Van Oers, B Leerkes.   

Abstract

In this study we have investigated five quantitative and three semi-quantitative rheumatoid factor assays and the Rose-Waaler assay in 120 patients suffering from rheumatoid arthritis and in 76 with other systemic diseases. All tests measure the IgM anti-IgG antibodies. The correlations between the quantitative tests were all higher than 0.86 and much better than between the quantitative and semi-quantitative tests and the semi-quantitative tests themselves (r between 0.22 and 0.85). The within run and between run precision studies for the quantitative tests showed CV values lower than 16%. In spite of the standardisation on the WHO and the Center of Disease Control Reference Preparation we found important differences in patient results. From an analytical point of view, the quantitative assays for rheumatoid factors show certain advantages over the traditional haemagglutination tests.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3235959     DOI: 10.1515/cclm.1988.26.12.863

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  2 in total

1.  Rheumatoid factor measurement--continuing problems 70 years after discovery.

Authors:  Rohan Ameratunga; Samarina Musaad; Claudia Sugrue; Campbell Kyle
Journal:  Clin Rheumatol       Date:  2011-04-01       Impact factor: 2.980

2.  Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.

Authors:  Tineke J van Wesemael; Sofia Ajeganova; Jennifer Humphreys; Chikashi Terao; Ammar Muhammad; Deborah P M Symmons; Alex J MacGregor; Ingiäld Hafström; Leendert A Trouw; Annette H M van der Helm-van Mil; Tom W J Huizinga; Tsuneyo Mimori; René E M Toes; Fumihiko Matsuda; Björn Svensson; Suzanne M M Verstappen; Diane van der Woude
Journal:  Arthritis Res Ther       Date:  2016-12-01       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.